These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
241 related articles for article (PubMed ID: 23280711)
1. Utility of subtyping intestinal metaplasia as marker of gastric cancer risk. A review of the evidence. González CA; Sanz-Anquela JM; Gisbert JP; Correa P Int J Cancer; 2013 Sep; 133(5):1023-32. PubMed ID: 23280711 [TBL] [Abstract][Full Text] [Related]
2. High-risk individuals for gastric cancer would be missed for surveillance without subtyping of intestinal metaplasia. Isajevs S; Savcenko S; Liepniece-Karele I; Piazuelo MB; Kikuste I; Tolmanis I; Vanags A; Gulbe I; Mezmale L; Samentaev D; Tazedinov A; Samsutdinov R; Belihina T; Igissinov N; Leja M Virchows Arch; 2021 Oct; 479(4):679-686. PubMed ID: 33990867 [TBL] [Abstract][Full Text] [Related]
3. CD10 and Das1: a biomarker study using immunohistochemistry to subtype gastric intestinal metaplasia. Koulis A; Di Costanzo N; Mitchell C; Lade S; Goode D; Busuttil RA; Boussioutas A BMC Gastroenterol; 2022 Apr; 22(1):197. PubMed ID: 35448971 [TBL] [Abstract][Full Text] [Related]
4. Incomplete type of intestinal metaplasia has the highest risk to progress to gastric cancer: results of the Spanish follow-up multicenter study. González CA; Sanz-Anquela JM; Companioni O; Bonet C; Berdasco M; López C; Mendoza J; Martín-Arranz MD; Rey E; Poves E; Espinosa L; Barrio J; Torres MÁ; Cuatrecasas M; Elizalde I; Bujanda L; Garmendia M; Ferrández Á; Muñoz G; Andreu V; Paules MJ; Lario S; Ramírez MJ; ; Gisbert JP J Gastroenterol Hepatol; 2016 May; 31(5):953-8. PubMed ID: 26630310 [TBL] [Abstract][Full Text] [Related]
6. Gene expression study and pathway analysis of histological subtypes of intestinal metaplasia that progress to gastric cancer. Companioni O; Sanz-Anquela JM; Pardo ML; Puigdecanet E; Nonell L; García N; Parra Blanco V; López C; Andreu V; Cuatrecasas M; Garmendia M; Gisbert JP; Gonzalez CA; Sala N PLoS One; 2017; 12(4):e0176043. PubMed ID: 28441455 [TBL] [Abstract][Full Text] [Related]
7. Gastric Cancer Risk of Intestinal Metaplasia Subtypes: A Systematic Review and Meta-Analysis of Cohort Studies. Du S; Yang Y; Fang S; Guo S; Xu C; Zhang P; Wei W Clin Transl Gastroenterol; 2021 Oct; 12(10):e00402. PubMed ID: 34597278 [TBL] [Abstract][Full Text] [Related]
8. Gastric cancer occurrence in preneoplastic lesions: a long-term follow-up in a high-risk area in Spain. González CA; Pardo ML; Liso JM; Alonso P; Bonet C; Garcia RM; Sala N; Capella G; Sanz-Anquela JM Int J Cancer; 2010 Dec; 127(11):2654-60. PubMed ID: 20178099 [TBL] [Abstract][Full Text] [Related]
9. CEACAM5 and TROP2 define metaplastic and dysplastic transitions in human antral gastric precancerous lesions and tumors. Jang B; Lee SH; Dovirak I; Kim H; Srivastava S; Teh M; Yeoh KG; So JB; Tsao SKK; Khor CJ; Ang TL; Goldenring JR Gastric Cancer; 2024 Mar; 27(2):263-274. PubMed ID: 38221567 [TBL] [Abstract][Full Text] [Related]
10. Relationship between endoscopic and histologic gastric atrophy and intestinal metaplasia. Quach DT; Le HM; Hiyama T; Nguyen OT; Nguyen TS; Uemura N Helicobacter; 2013 Apr; 18(2):151-7. PubMed ID: 23167960 [TBL] [Abstract][Full Text] [Related]
12. Outcome of intestinal metaplasia in gastric biopsy of patients with dyspepsia in Guilan Province, North Iran. Mansour-Ghanaei F; Joukar F; Soati F; Mansour-Ghanaei A; Atrkar-Roushan Z Asian Pac J Cancer Prev; 2013; 14(6):3549-54. PubMed ID: 23886143 [TBL] [Abstract][Full Text] [Related]
13. Risk of gastric cancer among patients with gastric intestinal metaplasia. Shao L; Li P; Ye J; Chen J; Han Y; Cai J; Lu X Int J Cancer; 2018 Oct; 143(7):1671-1677. PubMed ID: 29707766 [TBL] [Abstract][Full Text] [Related]
14. Cathepsin E and subtypes of intestinal metaplasia in carcinogenesis of the human stomach. Lin CK; Lai KH; Lo GH; Cheng JS; Hsu PI; Mok KT; Tseng HH Zhonghua Yi Xue Za Zhi (Taipei); 2001 Jun; 64(6):331-6. PubMed ID: 11534800 [TBL] [Abstract][Full Text] [Related]
15. Type or extension of intestinal metaplasia and immature/atypical "indefinite-for-dysplasia" lesions as predictors of gastric neoplasia. Tava F; Luinetti O; Ghigna MR; Alvisi C; Perego M; Trespi E; Klersy C; Fratti C; Fiocca R; Solcia E Hum Pathol; 2006 Nov; 37(11):1489-97. PubMed ID: 16949645 [TBL] [Abstract][Full Text] [Related]
16. Intestinal metaplasia of the gastric cardia. Morales TG; Sampliner RE; Bhattacharyya A Am J Gastroenterol; 1997 Mar; 92(3):414-8. PubMed ID: 9068460 [TBL] [Abstract][Full Text] [Related]
17. Gastric cancer risk in relation to Helicobacter pylori infection and subtypes of intestinal metaplasia. Wu MS; Shun CT; Lee WC; Chen CJ; Wang HP; Lee WJ; Lin JT Br J Cancer; 1998 Jul; 78(1):125-8. PubMed ID: 9662262 [TBL] [Abstract][Full Text] [Related]
18. Expression of GCRG213p, LINE-1 endonuclease variant, significantly different in gastric complete and incomplete intestinal metaplasia. Duan X; Lian H; Li J; Wu B; Wang W; Wu T; Wang C; Dou Y; Zhou Z; Wang B; Xue L; Wang G Diagn Pathol; 2019 Jun; 14(1):61. PubMed ID: 31221180 [TBL] [Abstract][Full Text] [Related]
19. SCHLAFEN 5 expression correlates with intestinal metaplasia that progresses to gastric cancer. Companioni Nápoles O; Tsao AC; Sanz-Anquela JM; Sala N; Bonet C; Pardo ML; Ding L; Simo O; Saqui-Salces M; Blanco VP; Gonzalez CA; Merchant JL J Gastroenterol; 2017 Jan; 52(1):39-49. PubMed ID: 27032393 [TBL] [Abstract][Full Text] [Related]
20. [Gastric dysplasia: its incidence in precancerous conditions, advanced cancer and early cancer]. Hojman D; Cenoz MC; Even L; Puzzo MA Acta Gastroenterol Latinoam; 1988; 18(4):231-48. PubMed ID: 3255219 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]